ADMA Biologics Q2 Earnings Preview: Expecting $0.14 EPS and $121.77M Revenue

ADMA Biologics is set to release Q2 2025 earnings on August 6th, with a consensus EPS estimate of $0.14 and revenue estimate of $121.77M (+13.6% Y/Y). Over the last 3 months, EPS estimates have seen a decline, while revenue estimates have remained relatively stable.

ADMA Biologics, Inc. (ADMA) is scheduled to release its second-quarter 2025 earnings on August 6th, with analysts expecting earnings of $0.14 per share and revenue of $121.77 million. The consensus estimate reflects a year-over-year growth rate of 13.6% in revenue, while earnings per share (EPS) estimates have seen a decline over the past three months.

In its previous quarterly report, ADMA Biologics reported a 40.2% increase in revenue year-over-year but missed earnings expectations, reporting $0.14 EPS against an anticipated $0.16. The company's revenue for the quarter was $114.80 million, compared to the consensus estimate of $116.40 million. The company's net margin was 45.01%, and its return on equity was 47.16%.

Over the past 90 days, revenue estimates for ADMA Biologics have remained relatively stable, with the full year 2025 revenue estimate at $0.51 billion. Conversely, earnings estimates have declined from $0.71 per share to $0.61 per share for the full year 2025 [1].

ADMA Biologics operates as an end-to-end commercial biopharmaceutical company, manufacturing, marketing, and developing specialty biologics for the treatment of immunodeficient patients and others at risk for infectious diseases. The company's products include ASCENIV™, BIVIGAM®, and NABI-HB®, with SG-001, a pre-clinical, investigative hyperimmune globulin targeting S. pneumonia, in development.

The company's management team will host a live conference call and audio webcast on August 6th at 4:30 p.m. ET to discuss its financial results and other updates. Investors are encouraged to register for the call to receive the dial-in numbers and unique PIN [2].

References:
[1] https://www.gurufocus.com/news/3035133/adma-biologics-inc-adma-q2-2025-earnings-report-preview-what-to-look-for
[2] https://www.biospace.com/press-releases/adma-biologics-to-report-second-quarter-2025-financial-results-on-august-6-2025